Table 1 Characteristics of patients and their diagnosis
Characteristics | FTS group (n = 128) | Conventional group (n =132) | P value |
|---|---|---|---|
Median age | 56.43 ± 13.28 | 55.72 ± 10.34 | 0.252 |
Gender | 0.973 | ||
Male | 103 (80.5) | 106 (80.3) | |
Female | 25 (19.5) | 26 (19.7) | |
Weight (kg) | 67.53 ± 14.37 | 66.45 ± 13.56 | 0.448 |
BMI (kg/m2) | 22.53 ± 2.85 | 22.89 ± 2.56 | 0.272 |
Operating time (min) | 168.98 ± 30.62 | 172.33 ± 24.67 | 0.438 |
Blood loss (ml) | 302.54 ± 88.48 | 312. 33 ± 76.73 | 0.727 |
Operative incision | 0.749 | ||
One | 44 (34.4) | 48 (36.4) | |
Two | 58 (45.3) | 62 (46.9) | |
Three | 26 (20.3) | 22 (16.7) | |
TNM | 0.773 | ||
I | 39 (30.5) | 36 (27.2) | |
II | 71 (55.4) | 79 (59.8) | |
III | 18 (14.1) | 17 (12.8) | |
IV | 0 (0) | 0 (0) | |
Pathology | 0.737 | ||
Adenocarcinoma | 7 (5.5) | 8 (6.1) | |
Squamous cell carcinoma | 116 (90.6) | 121 (91.6) | |
Other | 5 (3.9) | 3 (2.3) | |
Tumor location | 0.921 | ||
Upper esophagus | 12 (9.4) | 14 (10.6) | |
Mid esophagus | 73 (57.0) | 76 (57.6) | |
Distal esophagus | 43 (33.6) | 42 (31.8) | |
Neoadjuvant therapy | 0.988 | ||
Yes | 68 (53.1) | 70 (53.0) | |
No | 60 (46.9) | 62 (47.0) | |
Neoadjuvant regimen | 0.923 | ||
Neoadjuvant chemoradiotherapy | 27 (39.7) | 25 (35.7) | |
Neoadjuvant chemotherapy | 41 (60.3) | 45 (64.3) | |
pCR after Neoadjuvant therapy | 15 (22.1) | 17 (24.2) | 0.776 |
Surgical approach | 0.953 | ||
Conventional thoracotomy | 62 (48.4) | 66 (50.0) | |
Hybrid VATS | 41 (32.0) | 42 (31.8) | |
Pure VATS | 25 (19.6) | 24 (18.2) |